<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04274868</url>
  </required_header>
  <id_info>
    <org_study_id>2015-A00180-49</org_study_id>
    <nct_id>NCT04274868</nct_id>
  </id_info>
  <brief_title>Pediatric Hepatic Tumors</brief_title>
  <acronym>HEPATOBIO</acronym>
  <official_title>Constitution of a Centralized Biological Resources Collection and Associated With a Clinical Database for Childhood Liver Tumors Diagnosed in France (Retrospective Collection From 1990 and Prospective)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gustave Roussy, Cancer Campus, Grand Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Gustave Roussy, Cancer Campus, Grand Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Centralized biological collection of multicentric origin, retrospective and prospective of
      biological samples (tissues and fluids) taken within the framework of the diagnostic and
      therapeutic management of children and adolescents with liver tumor, and supported in the
      centers of French Society for Childhood Cancers (SFCE) with associated clinical database.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 10, 2015</start_date>
  <completion_date type="Anticipated">September 2025</completion_date>
  <primary_completion_date type="Anticipated">September 2025</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>Establish a national bank of rare biological material</measure>
    <time_frame>Up to 10 years</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Liver Tumor</condition>
  <arm_group>
    <arm_group_label>Children and adolescents with liver tumor</arm_group_label>
    <description>Patients treated after 01/01/1990 for a primary liver tumor before the age of 18.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients treated after 01/01/1990 for a primary liver tumor before the age of 18.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. - For inclusion in the clinical database:

               -  Children and adolescents (â‰¤18 years at diagnosis) suffering from a primary liver
                  tumor diagnosed after 01/01/1990 and treated in France

               -  Informed consent to the computerization of data signed by the patient or by
                  parents or legal representatives if he is a minor.

          2. - For inclusion in the biological collection (CRB Paris Sud):

               -  Additional criteria:

               -  Availability of biological samples (tumor tissue, healthy tissue, plasma and / or
                  serum).

               -  Informed consent to the use of biological remains signed by the patient or by
                  parents or legal representatives if he is a minor.

          3. - For the inclusion of deceased patients:

               -  Obtaining consent or failing this, seeking non-opposition to the computerization
                  of data (for inclusion in the database) and the use of biological remains (for
                  inclusion in the biological collection) of the patient or both parents or the
                  legal guardian if he is a minor.

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Brenda Mallon</last_name>
    <phone>0142114211</phone>
    <phone_ext>+33</phone_ext>
    <email>branda.mallon@gustaveroussy.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Gustave Roussy</name>
      <address>
        <city>Villejuif</city>
        <state>Val De Marne</state>
        <zip>94800</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Branda Mallon</last_name>
      <phone>0142114211</phone>
      <phone_ext>+33</phone_ext>
      <email>branda.mallon@gustaveroussy.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 17, 2020</study_first_submitted>
  <study_first_submitted_qc>February 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 18, 2020</study_first_posted>
  <last_update_submitted>February 17, 2020</last_update_submitted>
  <last_update_submitted_qc>February 17, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

